Prostate Cancer
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era - Abstract
February 9, 2015
A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer - Abstract
February 9, 2015
Association between changes in suspicious prostate lesions on serial MRI examinations and follow-up biopsy results - Abstract
February 9, 2015
Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective - Abstract
February 9, 2015
Management of low-risk prostate cancer - Abstract
February 7, 2015
Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy-user bias - Abstract
February 7, 2015
Psychometric properties and performance of the 17-item Benefit Finding Scale (BFS) in an outpatient population of men with prostate cancer - Abstract
February 7, 2015
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectom - Abstract
February 7, 2015
Active surveillance for prostate cancer: A systematic review of clinicopathologic variables and biomarkers for risk stratification - Abstract
February 7, 2015
Patterns of declining use and the adverse effect of primary androgen deprivation on all-cause mortality in elderly men with prostate cancer - Abstract
February 7, 2015
Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: A systematic review - Abstract
February 7, 2015
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate - Abstract
February 6, 2015